Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drug resistance albendazole

A. Liposomal amphotericin B was approved by the US. Food and Drug Administration to treat visceral leishmaniasis. Pentavalent antimony compounds, pentamidine, amphotericin B, and aminosi-dine (paromomycin) have all been demonstrated efficacious here. The liposomal amphotericin appears to be better taken up by the reticuloendothelial system, where the parasite resides, and partitions less in the kidney, where amphotericin B traditionally manifests its toxicity. In addition to being better tolerated by patients, it has proved to be very effective in India, where resistance to antimony drugs is widespread. This patient appears to have acquired his infection there, where many infected patients develop darkening of the skin, hence the name kala-azar, or black sickness. Albendazole, an anthelmintic, has no role here. Atovaquone, a naphthoquinone, is used to treat malaria, babesiosis, and pneumocystosis. Pyrimethamine-sulfadoxine is used to treat malaria and toxoplasmosis. Proguanil inhibits the dihydrofolate reductase of malaria parasites and is used in combination with atovaquone. [Pg.619]

Mepacrine (Fig. 25.14) can be used in resistant giardiasis. This drug was developed during the Second World War to treat malaria but has been re-introduced to treat giardiasis and is also the subject of research into the treatment of Alzheimer s disease. Albendazole may also be used as an alternative and is described below under the treatment of nematode infections. [Pg.520]


See other pages where Drug resistance albendazole is mentioned: [Pg.247]    [Pg.403]    [Pg.463]    [Pg.619]    [Pg.248]    [Pg.108]   
See also in sourсe #XX -- [ Pg.250 ]




SEARCH



Albendazol

Albendazole resistance

Drug resistance

Drug-resistant

© 2024 chempedia.info